Abstract:e16249 Background: Despite the epidemiological association between cholangiocarcinoma (CCA) and HBV infection, little is known about the relevant oncogenic biomarkers for advancing cancer research and improving future patient therapy. Radiomics-based non-invasive biomarkers are promising to facilitate the translation of therapeutically related molecular subtypes for treatment allocation of patients with HBV-infected CCA. Methods: In this study, we included 55 CCA patients with whole-genome multi-omics data, proteomic data with matched magnetic resonance imaging (MRI) data from institute 1. A total of 431 patients with histopathological confirmed CCA (143 HBV-positive and 288 HBV-negative patients) were retrospectively enrolled from three institutes, and patients were allocated to the training (n = 302) and validation (n = 129) cohorts from different institutes or time period (7:3). Utilizing linear regression and gene set enrichment analysis, we identified statistically significant associations between radiomic imaging and various genomic features in HBV-positive or HBV-negative CCA patients. Additionally, we employed a random forest classifier based on radiomic features to predict the status of HBV infection, HBV-related gene mutations and protein expression profiling, and tested on an internal and an external CCA cohort (n = 53). Results: The analysis revealed significant and widespread associations between genomic features (somatic mutations, transcriptional activities and copy number variations) and radiomic features characterizing HBV infection status. Our results show that quantitative image features are capable of distinguishing several molecular phenotypes. We obtained significant predictive performance for HBV+ (AUC = 0.73), CA-199(AUC = 0.77) and NeuroInvasion (AUC = 0.71), activation of ESRP1(AUC = 0.79) and mutation of HNRNPUL2/MUC4 (AUC = 0.73). We externally validated the HBV prediction model (AUC = 0.76) on the internal and external cohort. The sensitivity, specificity, and accuracy were all > 70%. The radiomic signature succeeded to stratify patients into distinct survival outcomes according to HBV status, and remained an independent prognostic factor in multivariable analysis (DFS, P < 0.0001; OS, P = 0.029). Integrating the radiomic signature with clinicopathological-radiographic factors further improved prediction performance. A nomogram incorporating significant pathological predictors (HBV, CA-125, CA-199, Neuro invasion, peritoneal invasion, pT stage, pN stage, and differentiation, grade) and radiomics signatures displayed good prediction performance in estimating OS with AUC values of 0.895, 0.935, and 0.907 at 1, 3, and 5 years, respectively. Conclusions: This deep learning-driven combined radiomics model may provide as a useful tool to preoperatively predict HBV infection and improve therapeutic management of ICC patients.

Integrating Pathomics and Radiomics for Predicting Survival among Patients with Intrahepatic Cholangiocarcinoma Undergoing Surgical Resection.

Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy

A nomogram based on radiomics to predict microvascular invasion and overall survival in intrahepatic cholangiocarcinoma

A radiomic nomogram based on CT images to predict survival outcomes in intrahepatic cholangiocarcinoma patients after resection

Survival prediction on intrahepatic cholangiocarcinoma with histomorphological analysis on the whole slide images

Machine learning-based multimodal prediction of prognosis in patients with resected intrahepatic cholangiocarcinoma.

Development and Validation of Combined Ki67 Status Prediction Model for Intrahepatic Cholangiocarcinoma Based on Clinicoradiological Features and MRI Radiomics

A Radiomics Approach Based on Support Vector Machine Using MR Images for Preoperative Lymph Node Status Evaluation in Intrahepatic Cholangiocarcinoma.

A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma

The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma

[Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics]

A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma

Associations between radiomic phenotypes and genomic mechanisms in HBV-associated cholangiocarcinoma.

Establishing prognostic models for intrahepatic cholangiocarcinoma based on immune cells

ASO Visual Abstract: Preoperative Microvascular Invasion Prediction to Assist in the Surgical Plan for Single Hepatocellular Carcinoma: Better Together with Radiomics

Prediction of Overall Survival in Resectable Intrahepatic Cholangiocarcinoma: ISICC -Applied Prediction Model.

Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma

Integrating intratumoral and peritumoral features to predict tumor recurrence in intrahepatic cholangiocarcinoma